Table of Contents
Multisystem Inflammatory Syndrome in Children (Pediatric)
It’s a rare but serious inflammatory response, most commonly seen after a COVID-19 infection.
What it is:
An overactive immune response
Causes widespread inflammation affecting multiple organs
Common features:
Persistent fever
GI symptoms (abdominal pain, vomiting, diarrhea)
Rash, red eyes, swollen lips/hands
Heart involvement (myocarditis, low blood pressure)
Fatigue, headache
Timing:
Usually appears 2–6 weeks after a viral infection (classically COVID-19)
Treatment:
Hospital care
IVIG, steroids, anti-inflammatory meds
Most kids recover well with early treatment
If this is about a specific child or symptoms, I can explain warning signs, how it’s diagnosed, or how it differs from Kawasaki disease.
Gotcha — here’s a DM-level (doctor/medical) clinical note on MIS-C (Multisystem Inflammatory Syndrome in Children), written in a professional charting style.
Diagnosis:
Multisystem Inflammatory Syndrome in Children (MIS-C)
Definition:
MIS-C is a post-infectious hyperinflammatory syndrome occurring in pediatric patients, most commonly following SARS-CoV-2 infection. It is characterized by persistent fever, systemic inflammation, and involvement of two or more organ systems.
Epidemiology:
Typically presents in children and adolescents weeks after acute or asymptomatic COVID-19 infection. Incidence is rare but clinically significant due to potential cardiovascular involvement.
Pathophysiology:
Believed to be an immune-mediated response rather than direct viral injury. Dysregulated immune activation leads to cytokine release, endothelial dysfunction, and multisystem inflammation.
Clinical Presentation:
Persistent fever (>38.0°C, ≥24 hours)
Gastrointestinal symptoms (abdominal pain, vomiting, diarrhea)
Mucocutaneous findings (rash, conjunctival injection, strawberry tongue, swollen extremities)
Cardiovascular involvement (myocarditis, depressed ejection fraction, hypotension, shock)
Neurologic symptoms (headache, altered mental status, irritability)
Respiratory symptoms may be minimal or absent
Laboratory Findings:
Elevated inflammatory markers (CRP, ESR, ferritin, procalcitonin)
Lymphopenia, thrombocytopenia
Elevated D-dimer, fibrinogen
Elevated cardiac markers (troponin, BNP/NT-proBNP)
Evidence of recent SARS-CoV-2 infection (PCR or serology)
Diagnosis:
Clinical diagnosis based on CDC/WHO criteria, requiring fever, laboratory evidence of inflammation, multisystem involvement, and temporal association with SARS-CoV-2 infection, with exclusion of alternative diagnoses.
Management:
Hospital admission; PICU if hemodynamically unstable
Immunomodulatory therapy: IVIG and systemic corticosteroids
Supportive care (fluids, vasopressors if indicated)
Anticoagulation in select cases
Cardiology consultation and echocardiographic monitoring
Prognosis:
With prompt recognition and treatment, prognosis is generally favorable. Most patients recover fully, though long-term cardiac follow-up is recommended.
